May Mo

2.7k citations
23 papers · 2.2k · 3 hit papers · h-index 11

Impact in

Papers in

    • Neutropenia and Cancer Infections 6
    • Cancer Treatment and Pharmacology 2
    • Asthma and respiratory diseases 5

May Mo

22 papers receiving 2.0k citations

May Mo's Hit Papers

Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial 2018 · 261 citations
2610+9+18Years since publication200400600

Peers

May Mo
Comparison fields: 5 of 90
  • Health 432
  • Immunology and Allergy 314
  • Dermatology 319
  • Physiology 764
  • Otorhinolaryngology 104
Replace De-min Han with:
De-min Han China
J Mark FitzGerald Canada
Mauro Niero Italy
G.J. Hordijk Netherlands
Henry C. Lin United States
Michael A. Wall United States
Dana Villines United States
Jeffrey Vietri United States
Christine de la Loge United States
Karen Gold United States
May Mo relative to De-min Han China De-min Han's profile →
Citations per field
00.5×8.8×
De-min Han · 1×
Citations per year

Countries citing papers authored by May Mo

Since Specialization
Citations

This map shows the geographic impact of May Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May Mo more than expected).

Fields of papers citing papers by May Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by May Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May Mo. The network helps show where May Mo may publish in the future.

Co-authors

The 25 scholars most cited alongside May Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with May Mo Line = papers co-authored together May Mo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tezepelumab in Adults with Uncontrolled Asthma
Hit paper breakdown →
2017722
2
A case for including spirituality in quality of life measurement in oncology
Hit paper breakdown →
1999685
3
Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial
Hit paper breakdown →
2018261
4 2011154
5 202076
6 202063
7 201051
8 199941
9 201028
10 202014
11 201412
12 20178
13 20097
14 20184
15 20134
16 20234
17 20134
18 20024
19 20204
20 20242

About May Mo

May Mo is a scholar working on Oncology, Physiology, Genetics, Statistics and Probability and Dermatology, having authored 23 papers that have together received 2.2k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (6 papers), Asthma and respiratory diseases (5 papers), Biosimilars and Bioanalytical Methods (3 papers), Statistical Methods in Clinical Trials (3 papers), Pharmaceutical studies and practices (3 papers), Allergic Rhinitis and Sensitization (2 papers), Cancer Treatment and Pharmacology (2 papers) and Dermatology and Skin Diseases (2 papers). The work is most often cited by research in Health (432 citations), Immunology and Allergy (314 citations), Dermatology (319 citations), Physiology (764 citations) and Otorhinolaryngology (104 citations). May Mo has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Marianne J. Brady, Amy H. Peterman, David Cella, George Fitchett, René van der Merwe, Jane R. Parnes, Janet M. Griffiths, Jonathan Corren, Stephanie L. Roseti and Eric L. Simpson. Their work appears in journals such as Journal of Clinical Oncology, Respiratory Research, Psycho-Oncology, Gastroenterology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact